The binding of modakafusp alfa via CD38 targeting moieties drives targeted IFN type I signaling to innate and adaptive immune cells and elicits direct anti-proliferative/apoptotic signals to tumor cells expressing CD38 (13, 14). This evidence concerns the gene CD38 and neoplasm.